India's pharmaceutical sector is widely expected to miss its 2030 sales target, as a combination of US import tariffs on generic drugs and prolonged shipping disruptions weigh on export momentum.…
Trump Unveils Phased Generic Drug Tariff Plan President Donald Trump has announced a phased tariff plan targeting imported generic pharmaceutical products, with rates escalating from 0% initially to 100% by…
On July 21-22, 2026, President Donald Trump unveiled a phased tariff plan on imported generic drugs, targeting the reshoring of pharmaceutical manufacturing to the United States. The announcement sent shockwaves…
The long-anticipated US-India bilateral trade deal is moving toward finalization, with major implications for India's generic pharmaceutical industry. US President Donald Trump confirmed at the G7 summit in Évian, France…